New Data Reveals Metformin’s Role in Early Pregnancy Success – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Don’t Stop Metformin at a Positive Test: New Data Shows Continuing Through Trimester 1 Cut Miscarriage Risk in Half
A massive new systematic review and meta-analysis published in the American Journal of Obstetrics and Gynaecology analysed data from over 1,700 women to settle the debate on metformin timing. The results showed that continuing metformin through the first trimester significantly boosted clinical pregnancy rates and reduced the odds of miscarriage by over 50% compared to stopping immediately upon confirmation. Researchers propose that abrupt stopping causes a harmful ‘insulin rebound’ effect during critical early fetal development.
A systematic review and meta-analysis of 12 Randomized Controlled Trials (n=1,708) published in the American Journal of Obstetrics and Gynecology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 13, 2026, 17:25From Contraception to Fertility Treatment, Reproductive Health Care Is a Human Right – ASRM
-
Nov 13, 2026, 17:15Discussing Planned Committee Projects and Much More with the ESGO Council
-
Nov 13, 2026, 17:08Don’t Forget the Male: An Interview with Francesco Lotti – ESHRE
-
Nov 13, 2026, 16:57Amos Grünebaum: 8 Tools, 1 Pregnancy, All Free
-
Nov 13, 2026, 16:51Amy Sparks: Humbled and Honored to Serve as President of the ASRM
-
Nov 13, 2026, 16:47New Preeclampsia Awareness Report Reveals Gaps in Preeclampsia Awareness – Preeclampsia Foundation
-
Nov 13, 2026, 16:40Ritik Shukla: Honoured to Welcome Suriyadeo Tripathi as a Keynote Speaker at GFWH 2026
-
Nov 13, 2026, 16:33RBMO Study Uses AI to Assess Shortened Embryo Warming Protocols
-
Nov 13, 2026, 16:26Joni Hetfield: How Kindbody Came Apart